Global Point of Care
Clinicians and laboratory professionals are encouraged to join this expert discussion for a clinical and scientific update on COVID-19 variants, infections, and post-COVID
conditions - known as “Long COVID”. Investigators and clinical experts will share updates on their research and seminal studies using rapid testing. Clinical and epidemiological perspectives on the value of accessible rapid testing for timely isolation and appropriate treatment, including antibiotic stewardship, will also be presented.
Cristina Agustí Benito, Bsc, MSc, PhD
Center for Epidemiological Studies of STI, HIV and AIDS of Catalonia (CEEISCAT)
Badalona, Barcelona, Spain
Marco Aurélio P. Sáfadi, MD, PhD
Head of the Department of Pediatrics
Santa Casa de São Paulo School of Medical Sciences
São Paulo, Brazil
Luis Gonzalez, MD, PhD
Medical and Scientific Affairs
A Leader in Rapid Point-of-Care Diagnostics.
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.